Literature DB >> 20209780

C-reactive protein, marker for evaluation of systemic inflammatory response in preeclampsia.

D Mihu1, N Costin, Carmen Mihaela Mihu, Ligia Daniela Blaga, Raluca Bogdana Pop.   

Abstract

AIM: Determination by a high sensitivity technique of serum C-reactive protein (CRP), a sensitive marker of inflammation in women with preeclampsia compared to normal pregnancy and investigation of the relationship between CRP and the severity of the preeclamptic syndrome. MATERIAL AND
METHOD: The study included 40 women with preeclampsia and 40 control subjects with normal pregnancies in the last trimester of pregnancy. The serum CRP concentration was determined using the universal high sensitivity immunoturbidimetric assay.
RESULTS: The serum CRP concentration was significantly higher (p < 0.001) in preclampsia (5.69 +/- 1.8 mg/L) compared to normal pregnancy (2.89 +/- 1.2 mg/L). In women with preeclampsia, CRP correlated positively and significantly with diastolic blood pressure, proteinuria and uric acid levels. Maternal CRP values also correlated negatively and significantly with fetal weight at birth.
CONCLUSIONS: Our results demonstrate that serum CRP is increased in preeclampsia and represents a marker of the severity of the preeclamptic syndrome and of fetal weight at birth. Taking into consideration these observations and the fact that CRP testing is rapid and relatively inexpensive, we recommend the use of this acute phase reagent in clinical practice, in all women with preeclampsia in order to establish the prognosis of the disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 20209780

Source DB:  PubMed          Journal:  Rev Med Chir Soc Med Nat Iasi        ISSN: 0048-7848


  8 in total

1.  TREM-1 expression is increased in human placentas from severe early-onset preeclamptic pregnancies where it may be involved in syncytialization.

Authors:  Ratana Lim; Gillian Barker; Martha Lappas
Journal:  Reprod Sci       Date:  2013-09-11       Impact factor: 3.060

Review 2.  Overview of procalcitonin in pregnancy and in pre-eclampsia.

Authors:  A Mangogna; C Agostinis; G Ricci; F Romano; R Bulla
Journal:  Clin Exp Immunol       Date:  2019-06-13       Impact factor: 4.330

3.  DNA methylation is altered in maternal blood vessels of women with preeclampsia.

Authors:  Ahmad A Mousa; Kellie J Archer; Renato Cappello; Guadalupe Estrada-Gutierrez; Christine R Isaacs; Jerome F Strauss; Scott W Walsh
Journal:  Reprod Sci       Date:  2012-08-17       Impact factor: 3.060

4.  Elevated maternal C-reactive protein and increased risk of schizophrenia in a national birth cohort.

Authors:  Sarah Canetta; Andre Sourander; Heljä-Marja Surcel; Susanna Hinkka-Yli-Salomäki; Jaana Leiviskä; Christoph Kellendonk; Ian W McKeague; Alan S Brown
Journal:  Am J Psychiatry       Date:  2014-09       Impact factor: 18.112

5.  The long-term impact of elevated C-reactive protein levels during pregnancy on brain morphology in late childhood.

Authors:  Anna Suleri; Elisabet Blok; Melisa Durkut; Anna-Sophie Rommel; Lot de Witte; Vincent Jaddoe; Veerle Bergink; Tonya White
Journal:  Brain Behav Immun       Date:  2022-04-02       Impact factor: 19.227

Review 6.  Is inflammation the cause of pre-eclampsia?

Authors:  Wenda Ramma; Asif Ahmed
Journal:  Biochem Soc Trans       Date:  2011-12       Impact factor: 5.407

Review 7.  Air pollution and children's health-a review of adverse effects associated with prenatal exposure from fine to ultrafine particulate matter.

Authors:  Natalie M Johnson; Aline Rodrigues Hoffmann; Jonathan C Behlen; Carmen Lau; Drew Pendleton; Navada Harvey; Ross Shore; Yixin Li; Jingshu Chen; Yanan Tian; Renyi Zhang
Journal:  Environ Health Prev Med       Date:  2021-07-12       Impact factor: 3.674

8.  Level of High Sensitive C-reactive Protein and Procalcitonin in Pregnant Women with Mild and Severe Preeclampsia.

Authors:  Reihane Jannesari; Elham Kazemi
Journal:  Adv Biomed Res       Date:  2017-11-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.